
CAS Number85409-38-7
Synonyms2-Oxazolamine, N-(dicyclopropylmethyl)-4,5-dihydro-, phosphate (1:1); N-(Dicyclopropylmethyl)-4,5-dihydro-1,3-oxazol-2-amine phosphate (1:1); Rilmenidine phosphate; 2-Oxazolamine, 4,5-dihydro-N-(dicyclopropylmethyl)-, phosphate (1:1); S 3341-3 {Phosphate}; Rilmenidine dihydrogen phosphate; S 3341-3; EINECS 287-106-2; 4,5-Dihydro-N-(dicyclopropylmethyl)-2-oxazolamine phosphate (1:1); Hyperium
Molecular FormulaC10H19N2O5P
Molecular Weight278.24
Purity98.00%
Boiling Point609.1ºC at 760 mmHg
Appearancepowder
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 85409-38-7 |
| Catalog No. | 2A-9049235 |
| Chinese Name | 磷酸利美尼定 |
| Synonyms | 2-Oxazolamine, N-(dicyclopropylmethyl)-4,5-dihydro-, phosphate (1:1); N-(Dicyclopropylmethyl)-4,5-dihydro-1,3-oxazol-2-amine phosphate (1:1); Rilmenidine phosphate; 2-Oxazolamine, 4,5-dihydro-N-(dicyclopropylmethyl)-, phosphate (1:1); S 3341-3 {Phosphate}; Rilmenidine dihydrogen phosphate; S 3341-3; EINECS 287-106-2; 4,5-Dihydro-N-(dicyclopropylmethyl)-2-oxazolamine phosphate (1:1); Hyperium |
| Molecular Formula | C10H19N2O5P |
| Molecular Weight | 278.24 |
| Purity | 98.00 |
| Boiling Point | 609.1ºC at 760 mmHg |
| Appearance | powder |
| Water Solubility | Freely soluble in water, slightly soluble in alcoh |
| Storage Condition | -20℃ |
| Application | Rilmenidine phosphate is a novel antihypertensive drug and orally active selective I1 imidazoline receptor agonist. Rilmenidine phosphate exerts central effects by reducing sympathetic overactivity an |
| HTC | 2934999090 |
| PubChem ID | 10262929 |
| SMILES | [P](=O)([O-])(O)O.[N+H2](C(C3CC3)C2CC2)C1=NCCO1 |
| InChI | 1S/C10H16N2O.H3O4P/c1-2-7(1)9(8-3-4-8)12-10-11-5-6-13-10;1-5(2,3)4/h7-9H,1-6H2,(H,11,12);(H3,1,2,3,4) |
| InChI Key | ZJCOWRFWZOAVFY-UHFFFAOYSA-N |
| NACRES Code | NA.24 |
| UNSPSC | 41116107 |
| MSDS | msds/49235_1_85409_38_7.pdf |
| Use of | Properties Name N-(dicyclopropylmethyl)-4,5-dihydro-1,3-oxazol-2-amine,phosphoric acid Synonym More Synonyms Rilmenidine phosphate Biological Activity Related Catalog Signaling Pathways >> Neuronal Signaling >> Imidazoline Receptor Signaling Pathways >> Apoptosis >> Apoptosis Research Areas >> Cardiovascular Disease Signaling Pathways >> GPCR/G Protein >> Imidazoline Receptor Signaling Pathways >> Autophagy >> Autophagy Signaling Pathways >> GPCR/G Protein >> Adrenergic Receptor In Vivo Rilmenidine phosphate-treated N171-82Q mice (i.p.; 4-times a week) displays significant improved forelimb grip strength and all limbs grip strength from 12 to 22 weeks of age[4]. Rilmenidine phosphate decreases levels of mutant huntingtin[4]. References [1]. Reid JL. Rilmenidine: a clinical overview. Am J Hypertens. 2000;13(6 Pt 2):106S-111S. [3]. Reid JL. Rilmenidine: a clinical overview. Am J Hypertens. 2000;13(6 Pt 2):106S-111S. [4]. Rose C, et al. Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease. Hum Mol Genet. 2010;19(11):2144-2153. Chemical & Physical Properties Molecular Formula C10H19N2O5P Exact Mass 278.103149 PSA 121.19000 LogP 0.04870 InChIKey ZJCOWRFWZOAVFY-UHFFFAOYSA-N Storage condition -20℃ Water Solubility Freely soluble in water, slightly soluble in alcohol, practically insoluble in methylene chloride. Toxicological Information CHEMICAL IDENTIFICATION RTECS NUMBER : CAS REGISTRY NUMBER : 85409-38-7 LAST UPDATED : DATA ITEMS CITED : MOLECULAR FORMULA : C10-H16-N2-O.H3-O4-P MOLECULAR WEIGHT : HEALTH HAZARD DATA ACUTE TOXICITY DATA TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : SPECIES OBSERVED : Rodent - rat DOSE/DURATION : TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : CDREEA Cardiovascular Drug Reviews. (Raven Press, 1185 Avenue of the Americas, New York, NY 10036) V.6- 1988- Volume(issue)/page/year: 8,56,1990 TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : CDREEA Cardiovascular Drug Reviews. (Raven Press, 1185 Avenue of the Americas, New York, NY 10036) V.6- 1988- Volume(issue)/page/year: 8,56,1990 Safety Information HS Code 2934999090 |
| Tax Rebate | 13.0% |
| Supervision | None. MFN tariff: 6.5%. Ordinary tariff: 20.0% |
| Transport Info | Product name: Summary 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
| Related Products in Specialty Chemicals | ||
|---|---|---|
| 4-(Benzyloxy)pyridin-2-amine | 85333-26-2 | 2A-9049225 |
| Methyl 4-chloro-2-(chlorosulfonyl)benzoate | 85392-01-4 | 2A-9049231 |
| 5-Decenoic acid | 85392-03-6 | 2A-9049232 |
| 6-Decenoic acid | 85392-04-7 | 2A-9049233 |
| C12-14-Alkyldimethyl(ethylbenzyl)ammonium chloride | 85409-23-0 | 2A-9049234 |
| 2'-Methyl-4-methoxydiphenylamine | 85448-89-1 | 2A-9049239 |
| Hydrogen hydroxy[2-hydroxy-3-[(2-hydroxy-3-nitrobenzylidene)amino]-5-nitrobenzenesulfonato(3-)]chromate(1-) 3-((2-ethylhexyl)oxy)-1-propanamine | 85455-32-9 | 2A-9049240 |
| 2-Bromo-5-chloro-4-fluoroaniline | 85462-59-5 | 2A-9049241 |
| 2,5-Dichlorobenzyl bromide | 85482-13-9 | 2A-9049245 |
| Aloe vera | 85507-69-3 | 2A-0201931 |
| Browse all Specialty Chemicals products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA